Loading…
Aspira Pathlab & Diagnostics (BSE 540788)₹126.95−4.98%Healthcare Service Provider
Aspira Pathlab & Diagnostics is compared with the 10 closest in size in Healthcare Service Provider (37 companies in the industry). It has a P/E of 2,115.8 against a peer median of 19.2, and ROCE of 2.9% against a peer median of 9.7%, and latest-quarter sales growth of 13.0% against a peer median of 12.5%. By market cap it is #4 of 11 in this set.
As of · Peer set: 10 closest in size in Healthcare Service Provider
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Chandan Healthcare | 587 | 23.6 | 23.0 | 13.3 | 0.31 | 0.0 | 276 | 20 | 19.0 | 28.2 | vs BSE 540788 |
| Pramodini Medicare | 237 | 10.3 | 42.0 | 39.0 | 0.34 | 0.0 | 62 | 17 | — | — | vs BSE 540788 |
| Choksi Laboratories | 139 | 69.3 | 9.7 | 6.1 | 1.19 | 0.0 | 46 | 2 | 12.5 | 12.1 | vs BSE 540788 |
| Aspira Pathlab & Diagnostics | 131 | 2,115.8 | 2.9 | 0.5 | 0.27 | 0.0 | 25 | 0 | 13.0 | −195.9 | — |
| Star Imaging and Path Lab | 125 | 6.5 | 26.0 | 23.5 | 0.18 | 0.0 | 89 | 19 | 4.8 | −10.0 | vs BSE 540788 |
| Invicta Diagnostic | 93 | 18.9 | 20.2 | 14.7 | 0.07 | 0.0 | 32 | 5 | — | — | vs BSE 540788 |
| Modern Diagnostic & Research Centre | 83 | 15.8 | 12.2 | 13.2 | 0.63 | 0.0 | 83 | 5 | — | — | vs BSE 540788 |
| Bandaram Pharma Packtech | 34 | 127.6 | 4.5 | 1.4 | 0.89 | 0.0 | 63 | 0 | 56.4 | 260.0 | vs BSE 540788 |
| N G Industries | 34 | 19.5 | 5.9 | 4.8 | 0.05 | 3.5 | 16 | 2 | −2.4 | — | vs BSE 540788 |
| Deccan Health Care | 30 | 12.3 | 3.3 | 2.3 | 0.04 | 0.0 | 82 | 3 | −0.4 | 21.7 | vs BSE 540788 |
| Samsrita Labs | 27 | — | −62.5 | −68.9 | 0.14 | 0.0 | 0 | −8 | — | — | vs BSE 540788 |
| Peer median | 93 | 19.2 | 9.7 | 6.1 | 0.27 | 0.0 | 62 | 3 | 12.5 | 16.9 |
Listed companies closest to Aspira Pathlab & Diagnostics in Healthcare Service Provider include Chandan Healthcare, Pramodini Medicare, Choksi Laboratories, Star Imaging and Path Lab, Invicta Diagnostic, Modern Diagnostic & Research Centre, Bandaram Pharma Packtech, N G Industries.
Chandan Healthcare, with a market cap of ₹587 Cr.
Aspira Pathlab & Diagnostics trades at a P/E of 2,115.8; the median of its peer set is 19.2. A P/E above or below the median is a description, not a judgement on value.
Aspira Pathlab & Diagnostics' return on capital employed is 2.9%, below the peer median of 9.7%.